← Back to Search

Procedure

Single Arm for Right Ventricular Dysfunction

N/A

Waitlist Available

Led By Benjamin W Kelemen, MD

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up during procedure. the measurement will be taken pre-rv pacing, with rv pacing, and 5 minutes after rv pacing. all catheters will then be removed and the study will be completed.

Awards & highlights

Study Summary

This trial will study if and how RV pacing can help people with PAH by looking at electrical activation in the RV, mapping the area of latest activation, and then evaluating the hemodynamic and energetic effects of RV pacing in these patients.

Eligible Conditions

Right Ventricular Dysfunction
Pulmonary Arterial Hypertension

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ during procedure. the measurement will be taken pre-rv pacing, with rv pacing, and 5 minutes after rv pacing. all catheters will then be removed and the study will be completed.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~during procedure. the measurement will be taken pre-rv pacing, with rv pacing, and 5 minutes after rv pacing. all catheters will then be removed and the study will be completed.

This trial's timeline: 3 weeks for screening, Varies for treatment, and during procedure. the measurement will be taken pre-rv pacing, with rv pacing, and 5 minutes after rv pacing. all catheters will then be removed and the study will be completed. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in contractility (Ees)

Secondary outcome measures

Change in stroke volume

Coronary sinus oxygen saturation

Pressure-volume loop area

Trial Design

1Treatment groups

Experimental Treatment

Group I: Single ArmExperimental Treatment1 Intervention

All patients will undergo hemodynamic measurements at baseline, with the intervention, and post-intervention thus serving as their own control.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor

2,507 Previous Clinical Trials

15,238,524 Total Patients Enrolled

Benjamin W Kelemen, MDPrincipal InvestigatorUniversity of California, San Francisco

Liviu Klein, MDPrincipal InvestigatorUniversity of California, San Francisco

4 Previous Clinical Trials

698 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Recent research and studies

clinicaltrials.govStudy

Right Ventricular Pacing in Pulmonary Arterial Hypertension

2021. "Right Ventricular Pacing in Pulmonary Arterial Hypertension". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04194632.

All > Pulmonary Arterial Hypertension

~4 spots leftby May 2025

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.